Labs in Court: A Full Circle
Cases filed or resolved by the U.S. Department of Justice in the fourth quarter reveal the same compliance issues from early in 2024
Cases filed or resolved by the U.S. Department of Justice in the fourth quarter reveal the same compliance issues from early in 2024
Recent False Claims Act settlements underscore the government’s emphasis on individual accountability in healthcare fraud matters
Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation
Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing
Genetic testing related fraud was a theme in recent enforcement actions involving medical laboratories and lab testing